BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32517406)

  • 1. The Current State of Opioid Prescribing and Drug Enforcement Agency (DEA) Action Against Physicians: An Analysis of DEA Database 2004-2017.
    Kim DD; Sibai N
    Pain Physician; 2020 Jun; 23(3):E297-E304. PubMed ID: 32517406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians charged with opioid analgesic-prescribing offenses.
    Goldenbaum DM; Christopher M; Gallagher RM; Fishman S; Payne R; Joranson D; Edmondson D; McKee J; Thexton A
    Pain Med; 2008 Sep; 9(6):737-47. PubMed ID: 18657218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of action by the Drug Enforcement Administration against physicians prescribing opioids for pain.
    Jung B; Reidenberg MM
    Pain Med; 2006; 7(4):353-7. PubMed ID: 16898947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prosecution of physicians for prescribing opioids to patients.
    Reidenberg MM; Willis O
    Clin Pharmacol Ther; 2007 Jun; 81(6):903-6. PubMed ID: 17329989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Prescriptions by Specialty in Ohio, 2010-2014.
    Weiner SG; Baker O; Rodgers AF; Garner C; Nelson LS; Kreiner PW; Schuur JD
    Pain Med; 2018 May; 19(5):978-989. PubMed ID: 28339965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Opioid Dispensing by Medical Specialties After the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.
    Salvatore PP; Guy GP; Mikosz CA
    Pain Med; 2022 Oct; 23(11):1908-1914. PubMed ID: 35482492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment.
    Gilson AM; Maurer MA; Joranson DE
    J Pain; 2007 Sep; 8(9):682-91. PubMed ID: 17627894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices.
    Togun AT; Karaca-Mandic P; Wurtz R; Jeffery MM; Beebe T
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1352-1364. PubMed ID: 34595944
    [No Abstract]   [Full Text] [Related]  

  • 11. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
    Guy GP; Zhang K; Bohm MK; Losby J; Lewis B; Young R; Murphy LB; Dowell D
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(26):697-704. PubMed ID: 28683056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician survey examining the impact of an educational tool for responsible opioid prescribing.
    Young A; Alfred KC; Davignon PP; Hughes LM; Robin LA; Chaudhry HJ
    J Opioid Manag; 2012; 8(2):81-7. PubMed ID: 22616313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Ambiguous and Restrictive Regulations on Opioid-Prescribing Practice in Georgia.
    Dzotsenidze P; Lekashvili T; Chikhladze N; Jorbenadze M; Abesadze I; Kordzaia D
    J Pain Symptom Manage; 2018 Jul; 56(1):63-71. PubMed ID: 29605272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Knowledge and Trends in Physicians' Prescribing of Opioids for New Onset Back Pain, 2009-2017.
    Gray BM; Vandergrift JL; Weng W; Lipner RS; Barnett ML
    JAMA Netw Open; 2021 Jul; 4(7):e2115328. PubMed ID: 34196714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of clinical competence, specialty and physician country of origin with opioid prescribing for chronic pain: a cohort study.
    Tamblyn R; Girard N; Boulet J; Dauphinee D; Habib B
    BMJ Qual Saf; 2022 May; 31(5):340-352. PubMed ID: 34725228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing?
    McCalmont JC; Jones KD; Bennett RM; Friend R
    J Opioid Manag; 2018; 14(2):103-116. PubMed ID: 29733096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline.
    Bohnert ASB; Guy GP; Losby JL
    Ann Intern Med; 2018 Sep; 169(6):367-375. PubMed ID: 30167651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses.
    Ringwalt C; Gugelmann H; Garrettson M; Dasgupta N; Chung AE; Proescholdbell SK; Skinner AC
    Pain Res Manag; 2014; 19(4):179-85. PubMed ID: 24809067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.
    Slevin KA; Ashburn MA
    J Opioid Manag; 2011; 7(2):109-15. PubMed ID: 21561034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.